Apotex Corp. and Centric Health Resources team up to help liver transplant patients obtain seamless care
Apotex Corp., maker of HepaGamB, and specialty pharmacy company Centric Health Resources have launched a program to help liver transplant patients transition from hospital to home. The HepaGamB Aftercare Access Program enables patients to receive the hepatitis B immune globulin intravenous (human) at home along with educational information, nursing services, help with obtaining reimbursement, and on-call support. More information is available at 1-(866) 588-6932.
To see more Daily News articles, click here.
To go to the Drug Topics homepage, click here.